Our current platform is just the beginning of a continuum of investment in next generation gene therapy technologies and capabilities. (lysogene.com)
Through the collaboration, Lysogene, UMMS and AU will develop IND - supporting preclinical studies in GM1 - gangliosidosis using AAV gene therapy technology. (lysogene.com)
Tissue engineering combined with gene therapy technology has the potential to manage the repair of defective articular cartilage. (sciencedaily.com)